Subject: Fwd: Compound Tirzepatide & Semaglutide Updates!
From: TJ Bourdeau <[email-masked]>
To: [email-masked]
Date: Tue, 17 Mar 2026 17:51:48 -0400

TJ

Begin forwarded message:

From: Dave Knapp from On The Pen <[email-masked]>
Date: March 17, 2026 at 4:03:57 PM EDT
To: [email-masked]
Subject: Compound Tirzepatide & Semaglutide Updates!
Reply-To: Dave Knapp from On The Pen <reply+35w1tf&4iwoe6&&[email-masked]>

Happy Spring Break to many of you!

͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏     ͏

Forwarded this email? Subscribe here for more

Compound Tirzepatide & Semaglutide Updates!

On The Pen GLP-1 News and Ann Metz

Mar 17

READ IN APP

Happy Spring Break to many of you! While Dave and I are taking a short break from MFW LIVE this week, the news is anything but quiet. Major developments are unfolding, and you can catch up on everything in the latest OTP podcast, where Dave breaks it all down.

In today’s episode, Dave explores several important topics, including:

Massive compound shakeup

Why compound users need this

Sponsor, Shed obesity care

Breaking news changed everything

OTP semaglutide exclusive

DDC list explained

Novo’s lab findings

302% dose shocker

Catalent’s contamination mess

Lilly’s B12 tirzepatide bombshell

Is the molecule changing?

New oral GLP-1 contender

MASSIVE: Compound Tirzepatide and Semaglutide Updates!

Dave Knapp GLP-1 Industry Insider

Episode

Do you trust compounded GLP-1s based on real-world experience, or do findings like the ones discussed today change your perspective?

Leave a comment

A guest post by

Ann Metz
Guest writer for https://onthepen.substack.com/

Subscribe to Ann

VISIT OUR SPONSORS!

You’re currently a free subscriber to On The Pen. For premium access to insider articles, upgrade to paid.

Upgrade to paid

Share

Like

Comment

Restack

© 2026 David Knapp
On The Pen, PO Box 541, Cedar Falls, IA 50613
Unsubscribe